Oleamide is an endogenous lipid that accumulates during sleep deprivation and has hypothermic effects when administered to rodents. The mechanisms for its activity remain unknown. Intraperitoneal injections of oleamide elicited dramatic increases in content of c-fos mRNA and Fos protein in distinct brain regions, including cingulate and somatosensory cortical areas and numerous nuclei of the thalamus and hypothalamus, indicating that there are explicit targets for its action. In the thalamus and hypothalamus a majority of neurons induced for c-fos expression also expressed the serotonin 5-HT 7 receptor, an allosteric target for oleamide in in vitro studies. These data suggest that oleamide may act at 5-HT 7 receptors to elicit alterations in transcription that result in some of its physiological effects. Key Words: Oleamide -c-fos-Hypothalamus-CNS -Serotonin-In situ hybridization.
Oleamide is a member of a growing family of biologically active amidated lipids. After its isolation from sleep-deprived cats (Lerner et al., 1994; Cravatt et al., 1995) , oleamide attracted attention as a potential sleepinducing agent, and studies have reported an increase in sleep after intraperitoneal injections in rats (Cravatt et al., 1995; Huitron-Resendiz et al., 1998) . Also, when injected intraperitoneally into rats, oleamide has been shown to decrease significantly core body temperature, an effect that lasts up to 4 h (Horn et al., 1998) . Given its lipidic structure, oleamide might be thought to exert its actions via panneural bath effects. Nevertheless, in vitro oleamide has been shown to modulate cellular signaling at several serotonin receptor subtypes, including 5-HT 2A/2C , 5-HT 7 , and 5-HT 1A (Huidobro-Toro and Harris, 1996; Thomas et al., 1997; Boger et al., 1998) , by either potentiating or inhibiting signaling events involving cyclic AMP and inositol phosphate pathways. Because disruption or enhancement of serotonin (5-HT) signaling can have a range of effects, including changes in appetite, alertness, psychiatric state of mind, sleep, and body temperature (for review, see Brewerton, 1995; Leonard, 1996) , the potential of oleamide to modify serotonergic neurotransmission in vivo is of great interest. The endogenous synthetic pathways of oleamide are not known; however, its degradative enzyme, fatty acid amide hydrolase, which converts oleamide to oleic acid, was recently cloned from rat, mouse, and human tissues (Cravatt et al., 1996; Giang and Cravatt, 1997) .
Membrane second messenger signals, such as cyclic AMP and inositol 1,4,5-trisphosphate, which are modulated by oleamide, can induce rapid and transient expression of immediate early genes, linking extracellular signals to long-term changes in gene expression (Berridge, 1986; Verma and Sassone-Corsi, 1987) . The immediate early gene c-fos is induced by various stimuli, including actions of neurotransmitters, drugs, ions, and growth factors (Morgan and Curran, 1986; Bartel et al., 1989; Sonnenberg et al., 1989; Graybiel et al., 1990; Sheng and Greenberg, 1990) , and is increasingly used as a marker for neuronal activation. The c-fos gene encodes the protein, c-Fos, which dimerizes with various members of the c-Jun family; the resulting heterodimer then binds to specific AP-1 promoter regions on chromosomal DNA, where it stimulates or represses transcription of particular genes, depending on the Jun family member with which Fos is complexed Sheng and Greenberg, 1990) . There is also a circadian regulation of the expression of basal c-fos and other immediate early genes (Grassi-Zucconi et al., 1993 Pompeiano et al., 1994a) . In the rat, basal c-fos expression was virtually undetectable in all brain areas studied during daylight hours (resting hours for the animal) but spontaneously increased, especially in the cortex and cerebellum, during nighttime (active hours) (Grassi-Zucconi et al., 1993) .
In this study, we investigated c-fos induction resulting from oleamide administration. We found that oleamide elicits increases in both c-fos mRNA and c-Fos protein in distinct neuronal populations of cerebral cortex, thalamus, and hypothalamus. Gene activation in these regions, hence, may mediate some of the physiological effects of oleamide. In addition, we demonstrate that Fos protein expression, induced by oleamide, is colocalized with 5-HT 7 receptor mRNA in neurons of the thalamus and hypothalamus. These data, in addition to the prior in vitro signaling studies described above, implicate serotonergic mechanisms in oleamide function. Furthermore, these results indicate that oleamide has explicit targets in which it alters patterns of transcription.
EXPERIMENTAL PROCEDURES

Animal procedures
Adult male mice (C57Bl6J, 6 -8 weeks old; Scripps Rodent Breeding Colony) were kept on a 12:12 h light:dark schedule (lights on at 0600 h) with ad libitum access to food and water. All injections were performed between the hours of 1100 and 1400 h to minimize circadian effects on c-fos expression (Grassi-Zucconi et al., 1993) . Mice received intraperitoneal injections of oleamide (1-10 mg/kg; dissolved in 100% ethanol and then diluted with 0.9% NaCl), oleic acid (10 mg/kg; dissolved in the same manner), vehicle (10% ethanol/90% saline), or 0.9% NaCl. Injection volumes were 0.5 ml per animal. Mice were returned to their home cages after injection and killed after 15 min to 4 h, by 5 min of halothane inhalation and intracardial perfusion with isotonic sodium phosphate buffer (PBS; pH 7.4) followed by perfusion with 4% paraformaldehyde in PBS. Brains were removed, postfixed in perfusion buffer for 12 h, cryoprotected in 30% sucrose and 4% paraformaldehyde for 12-48 h, and rapidly frozen at Ϫ70°C. Fixed, frozen brains were sliced into 25 m coronal sections and used for in situ hybridization and/or immunohistochemical analysis. All animal use procedures were in accordance with the NIH Guide for Care and Use of Laboratory Animals and were approved by the Animal Care and Use Committee at the Scripps Research Institute.
In situ hybridization analysis
In situ hybridization was performed on free-floating sections as described previously (de Lecea et al., 1996) . Coronal sections were hybridized at 55°C for 16 h with a 35 S-labeled, single-stranded antisense c-fos RNA probe at 10 7 cpm/ml. The probe was synthesized from a full-length cDNA clone of c-fos by using the Maxiscript Transcription Kit (Ambion, Austin, TX, U.S.A.). Excess probe was removed by washing with 2ϫ saline-sodium citrate (SSC; 1ϫ SSC ϭ 0.015 M NaCl and 0.0015 M sodium citrate) containing 14 mM ␤-mercaptoethanol (30 min), followed by incubation with 4 g/ml ribonuclease in 0.5 M NaCl, 0.05 M EDTA, and 0.05 M Tris-HCl (pH 7.5) for 1 h at 37°C. High-stringency washes were carried out at 55°C for 2 h in 0.5ϫ SSC, 50% formamide, and 0.01 M ␤-mercaptoethanol and then at 68°C for 1 h in 0.1ϫ SSC, 0.01 M ␤-mercaptoethanol, and 0.5% Sarkosyl. Slices were mounted onto gelatin-coated slides and dehydrated with ethanol and chloroform before autoradiography. Slides were exposed for 1-4 days to Kodak X-AR film and then dipped in Ilford K-5 emulsion. After 4 weeks, slides were developed with Kodak D19 developer, fixed, and counterstained with Richardson's blue. Cell counts were performed manually at 20ϫ and 40ϫ magnification.
Immunohistochemical analysis
Immunohistochemistry for c-Fos protein was performed using a specific c-Fos antibody (Calbiochem, La Jolla, CA, U.S.A.). The immunoreaction was detected with the Vectastain ABC kit (Vector Laboratory, Burlingame, CA, U.S.A.) according to the manufacturer's instructions. In brief, free floating sections were incubated with blocking solution (4% bovine serum albumin in 0.1% Triton X-100 and PBS) for 2 h at room temperature followed by incubation with anti-c-Fos serum (dilution, 1:10,000) in blocking solution for 16 -20 h at 4°C. Sections were then washed with 0.1% Triton X-100 and PBS, incubated with secondary biotinylated antibody (1:200 dilution in blocking solution) for 2 h at room temperature, washed with 0.1% Triton X-100 and PBS, incubated for 1 h with ABC reagent (1:1 dilution in blocking solution), and then washed finally with 0.1% Triton X-100 and PBS. Enzymatic development was performed in 0.05% diaminobenzidine in PBS containing 0.003% hydrogen peroxide for 3-5 min. For background control, sections were incubated without primary antibody.
RESULTS
To identify neuronal populations that might be activated by oleamide, we mapped changes in c-fos expression in the mouse brain in response to oleamide. Oleamide is an 18-carbon-chain fatty acid amide that has low solubility in aqueous solutions. Hence, in these studies, it was necessary first to dissolve oleamide in 100% ethanol and then to dilute with 0.9% NaCl, which resulted in a vehicle solution of 10% ethanol and 90% saline. Because moderate doses of alcohol have been shown to increase c-fos expression in certain rat brain regions (Ryabinin et al., 1997) , we tested the effect of the vehicle solution on c-fos mRNA expression in the brains of mice 45 min after injection. In situ hybridization revealed relatively similar patterns of c-fos expression in both saline-and vehicle-injected controls. The vehicle solution, however, did induce slight increases in c-fos expression over the saline-injected controls in a few brain regions, including somatosensory cortex, lateral septum, and the paraven- tricular nuclei of the hypothalamus and thalamus (data not shown), which are consistent with previous reports of c-fos induction caused by low levels of alcohol (Ryabinin et al., 1997) .
Administration of low doses of oleamide (1 mg/kg) to mice produced no overt effects on spontaneous behavior. However, at doses of 5-10 mg/kg, oleamide induced sedating effects and motor quiescence within 5 min postinjection and lasting between 2 and 3 h. No significant c-fos induction was detected at the low dose of oleamide, but at both 5 and 10 mg/kg doses, oleamide elicited increases in c-fos mRNA expression over vehicle in numerous, yet discrete, brain regions when measured at 45 min postinjection (Fig. 1) . These regions included anterior cingulate and somatosensory cortices, lateral septum, various thalamic nuclei (particularly paraventricular, central medial, and intermediodorsal nuclei), and various hypothalamic nuclei (particularly paraventricular, anterior, dorsomedial, and lateral nuclei). Induction of c-fos in all indicated brain regions peaked between 45 min and 2 h postinjection. By 4 h postinjection, the predominant c-fos expression was not much greater than basal levels (data not shown).
To test specificity for oleamide, mice were also injected with oleic acid, the product of oleamide hydrolysis by the degradative enzyme fatty acid amide hydrolase. In contrast to oleamide, oleic acid did not induce dramatic increases in c-fos expression in anterior cingulate cortex, somatosensory cortex (Fig. 1) , or lateral septum (Figs. 1  and 2 ). Oleic acid (10 mg/kg) did elicit increases in c-fos expression over vehicle in other brain regions, such as somatosensory cortex, the paraventricular thalamic nucleus, and some hypothalamic nuclei, such as the ventromedial hypothalamic nucleus, but not to the extent observed by oleamide (Fig. 1) .
At high magnification, induction of c-fos mRNA was observed in numerous thalamic nuclei, including paraventricular, intermediodorsal, central medial, and dorsal lateral geniculate thalamic nuclei, and several hypothalamic nuclei, such as paraventricular, anterior, lateral, dorsomedial, and arcuate nuclei (Table 1 and Fig. 2) . Also, strong c-fos mRNA hybridization signals were detected in numerous neurons of the anterior cingulate and somatosensory cortical regions 45 min after oleamide (10 mg/kg) injection (Fig. 3) . The most dramatic increases were detected in layers IV and VI (Fig. 3 and Table 1 ). In the hippocampus, oleamide had no effect on c-fos expression in the dentate gyrus or CA3 regions. However, a decrease in c-fos expression was detected in the pyramidal cells of the CA1 region (Table 1 ). In two particular regions of interest, the paraventricular thalamic and paraventricular hypothalamic nuclei, oleamide elicited not only an increase in the number of c-fospositive cells, but also an increase in the amount of c-fos hybridization per cell (Figs. 4 and 5 and Table 2 ).
To demonstrate that increases in c-fos mRNA expression were correlated with increases in Fos protein and to demonstrate the specificity of the in situ hybridization assay, we performed immunohistochemistry using an antibody specific for Fos protein. We observed similar patterns of Fos protein and c-fos mRNA expression throughout the brain 45 min after oleamide treatment. Fos immunoreactivity was increased in anterior cingulate and somatosensory cortical areas (Fig. 3) , as well as the paraventricular nucleus of the thalamus and hypothalamus (Figs. 4 and 5 ) and other brain regions. A decrease in Fos immunoreactivity was observed in the CA1 region of the hippocampus, but no significant changes were detected in the CA3 and dentate gyrus regions. Double-labeling studies using in situ hybridization and immunohistochemistry revealed that 5-HT 7 receptor mRNA and c-Fos protein induced by oleamide were colocalized in neurons of the hypothalamus and thalamus. Approximately 60 -70% of the Fos-positive cells induced by oleamide in the paraventricular nucleus of the thalamus were colocalized with 5-HT 7 receptor mRNA (Fig. 5) . Between 50 and 64% of the Fos-positive neurons in the dorsomedial and lateral hypothalamic nuclei were also double-labeled with 5-HT 7 receptor mRNA (data not shown). 5-HT 7 receptor mRNA is quite abundant throughout the thalamus and hypothalamus. It is notable that Fos-positive neurons represented 57% of the 5-HT 7 neurons in the paraventricular nucleus of the thalamus and between 23 and 40% in the dorsomedial and lateral hypothalamic nuclei. In the vehicle-injected mice, ϳ50 and 35% of the Fos-positive neurons in the paraventricular thalamic and hypothalamic nuclei, respectively, also contained 5-HT 7 receptor mRNA.
DISCUSSION
Using c-fos expression as a marker of neuronal activity, we have demonstrated that oleamide activates select cell populations in mouse brain, rather than having a panneural effect as was previously supposed. Intraperitoneal administration of oleamide at midday, a period during which mice are inactive, induced a transient induction of c-fos mRNA in numerous brain regions. The most outstanding c-fos inductions in response to oleamide were observed in cerebral cortex, hypothalamus, and thalamus. Substantial inductions were observed 45 min after oleamide administration but diminished to basal levels by 4 h postinjection, which is consistent with the duration of the observed sedative behavioral effects. At 45 min postinjection, we observed similar patterns of c-fos mRNA and Fos protein expression, although the times at which peak expression of each occurred were not precisely determined.
Previous studies by Grassi-Zucconi et al. (1993) have demonstrated spontaneous c-fos induction in rat brain during the activity period of the circadian cycle. Low c-fos expression was shown to be associated with electrical correlates of a state of sleep, whereas high c-fos expression was associated with electrical correlates of wakefulness (Grassi-Zucconi et al., 1993) . Sleep deprivation, induced by gentle handling, also elicits increases in c-fos expression, particularly in cingulate and neocortical regions (Grassi-Zucconi et al., 1993; Basheer et al., 1997) . It is interesting that in the states of sleep immediately following prolonged wakefulness, c-fos levels also remain high (Grassi-Zucconi et al., 1993; Basheer et al., 1997) . Oleamide was found to accumulate in the CSF of sleep-deprived cats; hence, its presence may be associated with a state of prolonged wakefulness (Lerner et al., 1994) . The sleep state induced by oleamide would be analogous to the recovery sleep following sleep deprivation, in which c-fos levels remain high, rather than decreasing on sleep as in the normal circadian cycle. Among the most prominent inductions of c-fos observed in the present study were in cingulate and neocortical regions, two regions displaying c-fos induction with sleep deprivation (Grassi-Zucconi et al., 1993; Basheer et al., 1997) .
The increases in c-fos expression detected in cortex and thalamus after oleamide administration are highly significant. Electroencephalographic activity that occurs during sleep and arousal is generated in the thalamus and cortex. These two brain regions are linked via multiple reciprocal projections and are thought to be intimately involved in the sleep-wake cycle (Lugaresi, 1992; Steriade et al., 1993) . We speculate that changes in gene expression, initiated by c-fos induction in these neurons, may modulate synaptic activity/inhibition that precludes or gives rise to a state of sleep.
The neuronal circuitry in the rostral hypothalamus is also thought to participate in generation of sleep (Sherin et al., 1996) . However, more notable is that distinct hypothalamic nuclei, including ventromedial, lateral, and anterior hypothalamic nuclei, are thought to be important integration sites for temperature regulation and sensing of core body temperature (Crawshaw et al., 1985; Atrens et al., 1987) . Indeed, numerous nuclei of the hypothala- mus were activated by oleamide administration, including lateral and anterior nuclei. The hypothermic responses measured after oleamide administration, hence, may be attributed to activation of these distinct neuronal groups in the hypothalamus. It is interesting that, as opposed to the c-fos induction observed in most brain regions after oleamide treatment, c-fos levels decreased in the CA1 region of the hippocampus. Because the hippocampus plays a critical role in certain aspects of memory formation and learning (Thompson and Kim, 1996) , this result may implicate an effect of oleamide on these processes.
It is well documented that various types of stressors can cause induction of c-fos in brain regions such as cerebral cortex, lateral septum, and the paraventricular nuclei of the thalamus and hypothalamus (for review, see Senba and Ueyama, 1997) . These regions, in addition to others, are also targets for oleamide (this study). However, oleamide's effects on c-fos are unlikely to be due primarily to typical stress-like actions. First, oleamide caused a decrease in c-fos expression in the CA1 region of the hippocampus and no change in the dentate gyrus/ CA3 regions. This is opposite from that observed on stress: Stress has been shown to cause an increase in c-fos and/or Fos protein expression in the CA1 region as well as in CA3 and dentate gyrus regions (Schreiber et al., 1991; Ryabinin et al., 1995) . Next, injection of oleic acid did not elicit c-fos induction in the same regions as oleamide, despite having a similar long-chained carbon structure. Oleic acid did not induce c-fos in lateral septum, cingulate cortex, or somatosensory cortex. If oleamide's effects resulted primarily from stress, one might expect similar induction patterns with oleic acid. Oleic acid did cause slight increases in the paraventricular nucleus of the thalamus and some hypothalamic nuclei as well. Because the paraventricular nucleus of the thalamus responds to many types of stressors, it is possible that some of the c-fos increases observed in this region could be due to yet undetermined stress resulting from a generalized interoceptive state caused by oleamide or oleic acid. In addition, it is possible that the oleamide's c-fos induction in the hypothalamic paraventricular nucleus might be a secondary response resulting from hypothermia, which has been suggested previously (Hare et al., 1995) .
Considering the modulatory role of oleamide on 5-HT receptor signaling, particularly via the 5-HT 2A/2C and 5-HT 7 receptors, it is interesting to note that the distribution of these receptor subtypes resembles to some extent the patterns of c-fos induction observed in this study. The 5-HT 2A and 5-HT 2C receptors are expressed in numerous brain regions, including areas observed here to contain cells that are targets for oleamide: cerebral cortex, hippocampus, lateral septum, and hypothalamus (Morilak et al., 1993; Pompeiano et al., 1994b) . The 5-HT 7 receptor has discrete expression in the rodent brain. Prominent 5-HT 7 receptor expression occurs throughout the thalamus, the CA3 regions of the hippocampus, and numerous hypothalamic nuclei, including dorsomedial, lateral, and arcuate nuclei (Lovenberg et al., 1993) . In neurons of the thalamus and hypothalamus, we observed that Fos protein was indeed colocalized with 5-HT 7 receptor mRNA. These correlations are consistent with the notion that oleamide modulates 5-HT signaling in vivo and that activation of 5-HT receptors may contribute to oleamide's physiological effects. Cell counts were performed manually at 20ϫ and 40ϫ magnification. Total cell counts for PVT and PVH are the same as in Fig. 1 . The percent increase in c-fos expression induced by oleamide treatment is indicated.
Significant effects of oleamide are shown: a p Ͻ 0.05, b p Ͻ 0.005 by two-tailed Student's t test.
